Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369717 | PMC |
| http://dx.doi.org/10.1097/CM9.0000000000003593 | DOI Listing |
Publication Analysis
Top Keywords
equivalence syn008
4
syn008 versus
4
versus omalizumab
4
omalizumab patients
4
patients refractory
4
refractory chronic
4
chronic spontaneous
4
spontaneous urticaria
4
urticaria multicenter
4
multicenter randomized
4
Similar Publications
Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study.
Chin Med J (Engl)
August 2025
Department of Dermatology, Peking University First Hospital, Beijing 100034, China.